Cargando…
CURRENT STATE OF SCIENCE ON DRUG THERAPIES FOR OSTEOPOROTIC FRACTURE PREVENTION
During the workshop, experts discussed the state of the science. The U.S. Food and Drug Administration (FDA) has approved several medications to prevent osteoporotic fractures. These include bisphosphonates (BPs), denosumab, teriparatide, estrogens, and selective estrogen-receptor modulators. BPs ar...
Autor principal: | Khosla, Sundeep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6846707/ http://dx.doi.org/10.1093/geroni/igz038.2744 |
Ejemplares similares
-
NIH PATHWAYS TO PREVENTION WORKSHOP: RESEARCH GAPS FOR LONG-TERM DRUG THERAPIES FOR FRACTURE PREVENTION
por: Joseph, Lyndon, et al.
Publicado: (2019) -
THE NIH PATHWAYS TO PREVENTION PROGRAM
por: Shropshire, Keisha L
Publicado: (2019) -
WORKSHOP PANEL REPORT ON EVIDENCE GAPS AND RESEARCH OPPORTUNITIES
por: Allore, Heather
Publicado: (2019) -
REPORT ON SYSTEMATIC EVIDENCE REVIEW
por: Fink, Howard
Publicado: (2019) -
The science of ultrasound therapy for fracture healing
por: Della Rocca, Gregory J
Publicado: (2009)